WallStreetZenWallStreetZen

NASDAQ: EIKN
Eikon Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Eikon Therapeutics earnings were -$333.6M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest EIKN earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$79.7M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EIKN reported annual earnings of -$333.6M, with 36.8% growth.

EIKN earnings history

Current Revenue
$0.0
Current Earnings
-$333.6M
Current Profit Margin
0%

EIKN Return on Equity

Insufficient data to display

EIKN Return on Assets

Current Company
-61.4%
Current Industry
-9.6%
EIKN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EIKN announces earnings.

EIKN Return on Capital Employed

Current Company
-59.92%
Current Industry
-3.7%

EIKN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EIKN-$299.24M-$333.64MN/A-$115.29
TECX-$69.37M-$74.15MN/A-$4.05
ZURA-$67.77M-$99.35MN/A-$1.06
MDXG$79.47M$48.58M-9.17%$0.33
OCGN-$59.00M-$67.85MN/A-$0.23
View Top Biotech Stocks

Eikon Therapeutics Earnings Reports & History FAQ

What were Eikon Therapeutics's earnings last quarter?

Eikon Therapeutics (NASDAQ: EIKN) reported Q4 2025 earnings per share (EPS) of -$26.23, up 7.72% year over year. Total EIKN earnings for the quarter were -$79.66 million. In the same quarter last year, Eikon Therapeutics's earnings per share (EPS) was -$24.35.

If you're new to stock investing, here's how to buy Eikon Therapeutics stock.

Is Eikon Therapeutics profitable or losing money?

As of the last Eikon Therapeutics earnings report, Eikon Therapeutics is currently losing money. Eikon Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$324.25 million, a 32.99% increase year over year.

What was EIKN's earnings growth in the past year?

As of Eikon Therapeutics's earnings date in Q2 2026, Eikon Therapeutics's earnings has grown year over year. EIKN earnings in the past year totalled -$333.64 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.